Quarterly Report II 16/17
September 2016 – February 2017, Diamyd Medical AB (publ), Fiscal year 2016/2017Reporting period, December 1, 2016 – February 28, 2017 · Net result amounted to MSEK -6.4 (-4.7) · Net result per share amounted to SEK -0.2 (-0.2) · Cash flow from operating activities amounted to MSEK -5.9 (-4.4) · Liquid assets and short term investments amounted at the end of the period to MSEK 20.6 (20.4) Half year, September 1, 2016 – February 28, 2017 · Net result amounted to MSEK -10.9 (-9.0) · Net result per share amounted to SEK -0.4 (-0.2) · Cash flow from operating
